cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Roivant Sciences Ltd
6 own
5 watching
Current Price
$9.31
$0.08
(0.87%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
6,766.55M
52-Week High
52-Week High
10
52-Week Low
52-Week Low
2.87
Average Volume
Average Volume
1.92M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization6,766.55M
icon52-Week High10
icon52-Week Low2.87
iconAverage Volume1.92M
iconDividend Yield--
iconP/E Ratio--
What does the Roivant Sciences Ltd do?
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
Read More
How much money does Roivant Sciences Ltd make?
News & Events about Roivant Sciences Ltd.
Globe Newswire
2 months ago
46.4% of subjects receiving VTAMA cream, 1% achieved the primary endpoint of Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-ADTM) response of clear (0) or almost clear (1) with at least a 2-grade improvement from baseline at Week 8, versus 18.0% on vehicle (PAll secondary ...
Globe Newswire
2 months ago
PVTX-321 and PVTX-405 Achieve Development Candidate NominationNEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Proteovant Therapeutics,aRoivant Sciences (Nasdaq: ROIV) company leveraging the process of protein degradation to discover and develop transformative medicines for the treatment of patients ...
Zolmax
3 months ago
Roivant Sciences Ltd. (NASDAQ:ROIV Get Rating) Director Vivek Ramaswamy sold 4,000,000 shares of the businesss stock in a transaction dated Wednesday, February 22nd. The shares were sold at an average price of $7.95, for a total value of $31,800,000.00. Following the completion of the transaction, ...
Globe Newswire
3 months ago
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) today announced that its founder Vivek Ramaswamy has stepped down from the companys board of directors to focus on his U.S. presidential campaign. Vivek founded Roivant in 2014 ...
Globe Newswire
3 months ago
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) today announced the pricing of an upsized underwritten public offering of 26,666,666 of its common shares at a price to the public of $7.50 per share. All of the common shares to ...
Frequently Asked Questions
Frequently Asked Questions
What is Roivant Sciences Ltd share price today?
plus_minus_icon
Can Indians buy Roivant Sciences Ltd shares?
plus_minus_icon
How can I buy Roivant Sciences Ltd shares from India?
plus_minus_icon
Can Fractional shares of Roivant Sciences Ltd be purchased?
plus_minus_icon
What are the documents required to start investing in Roivant Sciences Ltd stocks?
plus_minus_icon
What is today’s traded volume of Roivant Sciences Ltd?
plus_minus_icon
What is today’s market capitalisation of Roivant Sciences Ltd?
plus_minus_icon
What is the 52-Week High and Low Range of Roivant Sciences Ltd?
plus_minus_icon
What percentage is Roivant Sciences Ltd down from its 52-Week High?
plus_minus_icon
What percentage is Roivant Sciences Ltd up from its 52-Week Low?
plus_minus_icon
Current Price
$9.31
$0.08
(0.87%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00